Clinical assessment of collagen cross-linked N-telopeptides as a marker of bone metabolism in patients with primary hyperparathyroidism

Biomedicine and Pharmacotherapy

Volumn 53, Issue 7, 1999, Pages 329-333

  Takami, H ^a   Ikeda, Y ^a   Hayashi, K ^b   Hayashi, M ^b   Konishi, K ^b   Saruta, T ^b   Carpi, A ^c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Bone Gla protein; Collagen cross linked peptide; Primary hyperparathyroidism

Indexed keywords

COLLAGEN DERIVATIVE;

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE TURNOVER; DIAGNOSTIC VALUE; DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

EID: 0033178172     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(00)88506-6     Document Type: Article

References (11)

1. Clerkin EP. Hyperparathyroidism. In: Cady B, Rossi RL, eds. Surgery of the Thyroid and Parathyroid Glands. Philadelphia: Saunders; 1991. p. 243.
2. Price PA, Parthemore JG, Deftos LJ. New biochemical markers for bone Gla-protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980; 66 : 878.
3. Takami H, Shikata J. Serum bone Gla protein as an indicator of parathyroidectomy in patients with secondary hyperparathyroidsm. World J Surg 1990; 14 : 431.
4. Katagiri M, Fukunaga M, Ohtawa T, Harada T. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: Evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. World J Surg 1996; 20 : 753.
5. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992; 7 : 1251.
6. Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HK, et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994; 9 : 135.
7. Stein JA, Waltham MA, Lazewatsky JL, Hochberg AM. Dual-energy X-ray bone densitometer incorporating an internal reference system. Radiology 1987; 165 Suppl : 313.
8. Hauschka PF, Lian JB, Gallop PM. Direct identification of the calcium binding amino acid carboxyglutamate in mineralized tissue. Proc Nad Acad Sci USA 1975; 72 : 3925.
9. Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RGG, Riggs BL. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab 1992; 74 : 487.
10. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 1995; 80 : 729.
11. Guo CY, Thomas WEG, Al-Dehaimi AW, Assiri AMA, Eastell R. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81 : 3487.